• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PTEN的过表达通过抑制整合素αVβ6信号传导来抑制非小细胞肺癌转移。

Overexpression of PTEN suppresses non-small-cell lung carcinoma metastasis through inhibition of integrin αVβ6 signaling.

作者信息

Yu Yan Xia, Wang Yi, Liu Hong

机构信息

Cancer Treatment Research Center, Qilu Hospital of Shandong UniversityNo. 107, Wenhua West Road, Jinan, China.

出版信息

Am J Transl Res. 2017 Jul 15;9(7):3304-3314. eCollection 2017.

PMID:28804548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5553880/
Abstract

Studies have demonstrated that the abnormal expression of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is associated with multiple malignancies, but its functional role in non-small-cell lung carcinoma (NSCLC) metastasis remains to be elucidated. In the present study, we investigated the role of PTEN in regulating proliferation, migration, and invasion of NSCLC cells by establishing NSCLC cell strains with constitutively silenced or elevated PTEN expression. We demonstrated that ectopic expression of PTEN inhibits migration and invasion of NSCLC cells in vitro through wound healing and Transwell invasion assays. Furthermore, PTEN overexpression in NSCLC cells greatly inhibits cell viability and colony formation, which was confirmed by MTT and colony formation assays. Conversely, further analysis indicated that suppression of PTEN expression via shRNA promotes metastasis and growth of NSCLC cells. Finally, our findings demonstrate that PTEN promotes invasion and migration of NSCLC cells through the integrin αVβ6 signaling pathway. Overall, this study provides novel insights into the role of PTEN as a crucial regulator of NSCLC cell metastasis, and suggests that targeted treatment of PTEN-expressing tumors serves as a new therapeutic target for NSCLC.

摘要

研究表明,10号染色体缺失的磷酸酶及张力蛋白同源物(PTEN)的异常表达与多种恶性肿瘤相关,但其在非小细胞肺癌(NSCLC)转移中的功能作用仍有待阐明。在本研究中,我们通过建立PTEN表达持续沉默或升高的NSCLC细胞株,研究了PTEN在调节NSCLC细胞增殖、迁移和侵袭中的作用。我们通过伤口愈合和Transwell侵袭实验证明,PTEN的异位表达在体外抑制NSCLC细胞的迁移和侵袭。此外,NSCLC细胞中PTEN的过表达极大地抑制了细胞活力和集落形成,MTT和集落形成实验证实了这一点。相反,进一步分析表明,通过shRNA抑制PTEN表达可促进NSCLC细胞的转移和生长。最后,我们的研究结果表明,PTEN通过整合素αVβ6信号通路促进NSCLC细胞的侵袭和迁移。总体而言,本研究为PTEN作为NSCLC细胞转移关键调节因子的作用提供了新的见解,并表明针对表达PTEN的肿瘤进行靶向治疗可作为NSCLC的新治疗靶点。

相似文献

1
Overexpression of PTEN suppresses non-small-cell lung carcinoma metastasis through inhibition of integrin αVβ6 signaling.PTEN的过表达通过抑制整合素αVβ6信号传导来抑制非小细胞肺癌转移。
Am J Transl Res. 2017 Jul 15;9(7):3304-3314. eCollection 2017.
2
CCNA2 facilitates epithelial-to-mesenchymal transition via the integrin αvβ3 signaling in NSCLC.CCNA2通过非小细胞肺癌中的整合素αvβ3信号通路促进上皮-间质转化。
Int J Clin Exp Pathol. 2017 Aug 1;10(8):8324-8333. eCollection 2017.
3
MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.微小 RNA-92a 通过激活 PTEN/PI3K/AKT 信号通路促进非小细胞肺癌转移中的上皮-间充质转化。
Int J Oncol. 2017 Jul;51(1):235-244. doi: 10.3892/ijo.2017.3999. Epub 2017 May 16.
4
Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer.长链非编码 RNA ASAP1-IT1 通过 PTEN/AKT 信号轴促进非小细胞肺癌细胞的增殖、侵袭和转移。
Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):142-149. doi: 10.26355/eurrev_201801_14111.
5
Fms related tyrosine kinase 1 (Flt1) functions as an oncogene and regulates glioblastoma cell metastasis by regulating sonic hedgehog signaling.Fms相关酪氨酸激酶1(Flt1)作为一种癌基因,通过调节音猬因子信号传导来调控胶质母细胞瘤细胞的转移。
Am J Cancer Res. 2017 May 1;7(5):1164-1176. eCollection 2017.
6
MicroRNA-19a promotes proliferative and migratory abilities of NSCLC cells by inhibiting PTEN expression.微小RNA-19a通过抑制PTEN表达促进非小细胞肺癌细胞的增殖和迁移能力。
J BUON. 2019 May-Jun;24(3):955-962.
7
miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.微小RNA-106a通过靶向磷酸酶和张力蛋白同源物促进非小细胞肺癌的生长和转移。
Int J Clin Exp Pathol. 2015 Apr 1;8(4):3827-34. eCollection 2015.
8
miR-543 is up-regulated in gefitinib-resistant non-small cell lung cancer and promotes cell proliferation and invasion via phosphatase and tensin homolog.miR-543在吉非替尼耐药的非小细胞肺癌中上调,并通过磷酸酶和张力蛋白同源物促进细胞增殖和侵袭。
Biochem Biophys Res Commun. 2016 Nov 18;480(3):369-374. doi: 10.1016/j.bbrc.2016.10.055. Epub 2016 Oct 18.
9
PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.PTEN 通过协调降低 MMP 表达来抑制 HepG2 细胞的迁移和侵袭,途径是 PI3K/Akt 通路。
Oncol Rep. 2010 Jun;23(6):1593-600. doi: 10.3892/or_00000800.
10
PTEN and Ki67 expression is associated with clinicopathologic features of non-small cell lung cancer.PTEN和Ki67的表达与非小细胞肺癌的临床病理特征相关。
J Biomed Res. 2014 Nov;28(6):462-7. doi: 10.7555/JBR.27.20130084. Epub 2013 Dec 25.

引用本文的文献

1
CRISPR/Cas9-mediated knock out of ITGB6 in human OSCC cells reduced migration and proliferation ability.CRISPR/Cas9 介导的人口腔鳞状细胞癌细胞中 ITGB6 的敲除降低了迁移和增殖能力。
Head Face Med. 2024 Jun 18;20(1):37. doi: 10.1186/s13005-024-00437-x.
2
Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer.PTEN在非小细胞肺癌中的治疗意义
Pharmaceutics. 2023 Aug 5;15(8):2090. doi: 10.3390/pharmaceutics15082090.
3
Hypoxic Microenvironment-Induced Reduction in PTEN-L Secretion Promotes Non-Small Cell Lung Cancer Metastasis through PI3K/AKT Pathway.缺氧微环境诱导的PTEN-L分泌减少通过PI3K/AKT途径促进非小细胞肺癌转移。
Evid Based Complement Alternat Med. 2022 Mar 2;2022:6683104. doi: 10.1155/2022/6683104. eCollection 2022.
4
Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review.基于纳米材料的肺癌治疗新进展:综述。
Curr Med Chem. 2023;30(3):335-355. doi: 10.2174/0929867328666210810160901.
5
Overcoming of Radioresistance in Non-small Cell Lung Cancer by microRNA-320a Through HIF1α-Suppression Mediated Methylation of PTEN.微小RNA-320a通过抑制缺氧诱导因子1α介导的PTEN甲基化克服非小细胞肺癌的放射抗性
Front Cell Dev Biol. 2020 Nov 10;8:553733. doi: 10.3389/fcell.2020.553733. eCollection 2020.
6
Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?改变与在癌症管理中的作用:我们是否在精准医学方面取得了进展?
Genes (Basel). 2020 Jun 28;11(7):719. doi: 10.3390/genes11070719.
7
Clinical Significance of C-X-C Motif Chemokine Receptor 4 and Integrin αvβ6 Expression in Breast Cancer.C-X-C基序趋化因子受体4和整合素αvβ6在乳腺癌中的表达的临床意义
J Breast Cancer. 2020 Apr;23(2):171-181. doi: 10.4048/jbc.2020.23.e23.
8
MicroRNA in Lung Cancer Metastasis.微小RNA与肺癌转移
Cancers (Basel). 2019 Feb 23;11(2):265. doi: 10.3390/cancers11020265.
9
miR-106a contributes to prostate carcinoma progression through PTEN.微小RNA-106a通过磷酸酶和张力蛋白同源物(PTEN)促进前列腺癌进展。
Oncol Lett. 2019 Jan;17(1):1327-1332. doi: 10.3892/ol.2018.9697. Epub 2018 Nov 14.
10
MicroRNA-214 inhibits the proliferation and invasion of lung carcinoma cells by targeting JAK1.微小RNA-214通过靶向JAK1抑制肺癌细胞的增殖和侵袭。
Am J Transl Res. 2018 Apr 15;10(4):1164-1171. eCollection 2018.

本文引用的文献

1
Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells.抑制RAB1A可抑制三阴性乳腺癌细胞的上皮-间质转化和增殖。
Oncol Rep. 2017 Mar;37(3):1619-1626. doi: 10.3892/or.2017.5404. Epub 2017 Jan 25.
2
MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.微小 RNA-130b 通过 PI3K/Akt 信号通路靶向 PTEN 介导乳腺癌细胞的耐药性和增殖。
Sci Rep. 2017 Feb 6;7:41942. doi: 10.1038/srep41942.
3
Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression.miR-205 的转录上调抑制 SMAD4 和 PTEN,促进人卵巢癌的进展。
Sci Rep. 2017 Feb 1;7:41330. doi: 10.1038/srep41330.
4
Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy.整合素/黏着斑激酶信号轴和c-Myc的抑制协同破坏卵巢癌的恶性肿瘤特性。
Oncogenesis. 2017 Jan 30;6(1):e295. doi: 10.1038/oncsis.2016.86.
5
MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A.微小RNA-101通过靶向DNA甲基转移酶3A,经由PTEN/AKT信号通路抑制肺癌进展。
Oncol Lett. 2017 Jan;13(1):329-338. doi: 10.3892/ol.2016.5423. Epub 2016 Nov 23.
6
Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways.PTEN/AKT信号通路的抑制通过ATP和半胱天冬酶-3信号通路降低了TUBB3和TOP2A的表达,随后抑制了人乳腺癌MCF-7细胞的生长并诱导了细胞凋亡。
Oncol Rep. 2017 Feb;37(2):1011-1019. doi: 10.3892/or.2017.5358. Epub 2017 Jan 9.
7
Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles.呈现不同表皮生长因子受体(EGFR)和第10号染色体缺失的磷酸酶和张力蛋白同源物(PTEN)分子特征的多原发性肺癌
Oncotarget. 2016 Dec 6;7(49):81969-81971. doi: 10.18632/oncotarget.13046.
8
Integrin β4 is a controversial target for non-small cell lung cancer-reply.整合素β4是一个针对非小细胞肺癌的有争议的靶点——回复。
Hum Pathol. 2017 Mar;61:223-224. doi: 10.1016/j.humpath.2016.09.032. Epub 2016 Nov 2.
9
Intracellular delivery of the PTEN protein using cationic lipidoids for cancer therapy.利用阳离子脂质体将 PTEN 蛋白递送至细胞内用于癌症治疗。
Biomater Sci. 2016 Nov 15;4(12):1773-1780. doi: 10.1039/c6bm00580b.
10
Matrix metalloproteinase expression and molecular interaction network analysis in gastric cancer.胃癌中基质金属蛋白酶的表达及分子相互作用网络分析
Oncol Lett. 2016 Oct;12(4):2403-2408. doi: 10.3892/ol.2016.5013. Epub 2016 Aug 16.